Your browser doesn't support javascript.
loading
Checklist for studies of HIV drug resistance prevalence or incidence: rationale and recommended use.
Mbuagbaw, Lawrence; Garcia, Cristian; Brenner, Bluma; Cecchini, Diego; Chakroun, Mohamed; Djiadeu, Pascal; Holguin, Africa; Mor, Orna; Parkin, Neil; Santoro, Maria M; Ávila-Ríos, Santiago; Fokam, Joseph; Phillips, Andrew; Shafer, Robert W; Jordan, Michael R.
Afiliação
  • Mbuagbaw L; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada; Department of Anesthesia, McMaster University, Hamilton, ON, Canada; Department of Pediatrics, McMaster University, Hamilton, ON, Canada; Biostatistics Unit, Father Sean O'Sullivan Research Centre,
  • Garcia C; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
  • Brenner B; McGill Centre for Viral Diseases, Lady Davis Institute for Medical Research, Montréal, QC, Canada; Department of Microbiology and Immunology, McGill University, Montréal, QC, Canada; Department of Medicine, Surgery, and Infectious Disease, McGill University, Montréal, QC, Canada.
  • Cecchini D; Hospital General de Agudos Dr. Cosme Argerich, Buenos Aires, Argentina; Helios Salud, Buenos Aires, Argentina.
  • Chakroun M; Infectious Diseases Department, Fatouma Bourguiba University Hospital, Monastir, Tunisia.
  • Djiadeu P; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada; Yale University School of Nursing, Yale University, West Haven, CT, USA; Centre for Urban Health Solutions, St Michael's Hospital, Toronto, ON, Canada.
  • Holguin A; HIV-1 Molecular Epidemiology Laboratory, Microbiology and Parasitology Department, Hospital Ramón y Cajal-IRYCIS and CIBEREsp-RITIP, Madrid, Spain.
  • Mor O; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Central Virology Laboratory, Ministry of Health and Sheba Medical Centre, Tel-Hashomer, Israel.
  • Parkin N; Data First Consulting, Sebastopol, CA, USA.
  • Santoro MM; Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.
  • Ávila-Ríos S; Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico; Centro de Investigaciones en Enfermedades Infecciosas, Mexico City, Mexico.
  • Fokam J; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon; Faculty of Health Science, University of Buea, Buea, Cameroon; National HIV Drug Resistance Working Group, Ministry of Public Health, Yaoundé, Cameroon.
  • Phillips A; Institute for Global Health, University College London, London, UK.
  • Shafer RW; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA, USA.
  • Jordan MR; Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, MA, USA; Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, USA; Tufts Center for Integrated Management of Antimicrobial Resistance, Tufts University School of Med
Lancet HIV ; 10(10): e684-e689, 2023 10.
Article em En | MEDLINE | ID: mdl-37716367
ABSTRACT
HIV drug resistance (HIVDR) is a major challenge to the effectiveness of antiretroviral therapy. Global efforts in addressing HIVDR require clear, transparent, and replicable reporting in HIVDR studies. We describe the rationale and recommended use of a checklist that should be included in reports of HIVDR incidence and prevalence. After preliminary consultations with experts on HIVDR and establishing the need for guidance on HIVDR reporting, we used a sequential, explanatory, mixed methods approach to create the checklist; together with the accompanying articles, the checklist was reviewed by the authors and validated externally. The checklist for studies on HIVDR prevalence or incidence (CEDRIC-HIV) includes 15 recommended items that would enhance transparency and facilitate interpretation, comparability, and replicability of HIVDR studies. CEDRIC-HIV will help authors of HIVDR studies prepare research reports and assist reviewers and editors in assessments of completeness of reporting. The checklist will also facilitate statistical pooling and interpretation of HIVDR data.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV Idioma: En Ano de publicação: 2023 Tipo de documento: Article